Q
QNCX//CIK 0001662774
Quince Therapeutics, Inc.
Market Data
$1.17+$0.10 (+9.35%)
QNCX · Last trade
Prev Close
$1.07
Range (30d)
$0.80 – $1.83
Recent Filings
- 10-K16.8 MBQuince Therapeutics, Inc.Apr 10, 4:35 PM ET·0001193125-26-151364
- 8-K158.1 KBQuince Therapeutics, Inc.Apr 9, 9:23 AM ET·0001193125-26-149021
- 8-K162.2 KBQuince Therapeutics, Inc.Mar 30, 8:35 AM ET·0001193125-26-130489
- 8-K144.2 KBQuince Therapeutics, Inc.Mar 20, 4:45 PM ET·0001193125-26-117794
- 8-K156.0 KBQuince Therapeutics, Inc.Feb 12, 6:06 AM ET·0001193125-26-047544
- 8-K135.4 KBQuince Therapeutics, Inc.Feb 2, 4:30 PM ET·0001193125-26-033758
- 8-K169.1 KBQuince Therapeutics, Inc.Jan 29, 4:40 PM ET·0001193125-26-029524
- 10-Q12.8 MBQuince Therapeutics, Inc.Nov 12, 11:05 AM ET·0001193125-25-277529
- 8-K477.1 KBQuince Therapeutics, Inc.Nov 12, 11:05 AM ET·0001193125-25-277523
- 8-K138.8 KBQuince Therapeutics, Inc.Oct 17, 4:11 PM ET·0001193125-25-242514
Insiders
10- Benatti LucaDirector
- Boeding Chad10% Owner
- Bray JuneDirector
- Detke Michael J.Chief Medical Officer
- Dominy Stephen S.Director, Chief Scientific Officer
- EPIQ Capital Group, LLCIA/Managing Member 10% owner
- Gafric KristenSVP, Legal & Administration
- Hannah BrendanCBO, COO & CCO
- Holsinger LeslieExecutive Vice President
- Janhofer GuenterChief Scientific Officer
Tickers
Addresses
business
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA, 94080
mailing
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Cortexyme, Inc.2022-08-01